Advertisement

New Treatment Options in Bladder Cancer
Posted: 07/12/2022 | By: Melissa E. Fryman, MS

At the NCCN 2022 Annual Conference, Thomas Flaig, MD, Professor of Medicine, Vice Chancellor for Research, University of Colorado Anschutz Medical Campus, and Chair of the NCCN Guidelines Panel for Bladder Cancer, presented information on new treatment options in bladder cancer, as well as updates to the NCCN Guidelines for Bladder Cancer.

Question 1 of 5

Per the National Comprehensive Cancer Network (NCCN) Guidelines, therapy for patients with high-risk, non-muscle invasive bladder cancer should prioritize which of the following?

Choose 1